| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106045 Spiroindolinepiperidine derivatives |
| 05/18/2006 | US20060106018 treating or ameliorating a reactive oxygen species mediated inflammatory disorder as interleukin-2 mediated disorder, inflammatory arthritis, Alzheimer's disease; inhibitors of nicotinamide adenine dinucleotide oxidase; N1-[2-[4-[(4-chlorophenyl)ethynyl]phenoxy]ethyl]-N4-propyl-1,4-benzenedimethanamine |
| 05/18/2006 | CA2586156A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 05/17/2006 | EP1656350A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 05/17/2006 | EP1656349A1 Cyclopropyl derivatives as nk3 receptor antagonists |
| 05/17/2006 | EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656341A1 Prodrugs of 9-aminomethyl tetracycline compounds |
| 05/17/2006 | EP1355882B1 Chiral scaffolds and their preparation |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | CN1774433A Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| 05/17/2006 | CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 05/17/2006 | CN1772735A Antifungal compound and its prepn process and application |
| 05/17/2006 | CN1772734A Antifungal compound and its prepn process and application |
| 05/17/2006 | CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/16/2006 | US7045647 Synergistic mixture of a nitroxyl compound with a quinone alkide having an electron withdrawing group at the 7-position; purification of unsaturated compounds; effective during steady state and after shutoff; storage stability |
| 05/16/2006 | US7045630 Method for preparing 4-amino-4-phenylpiperidines |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/16/2006 | CA2192535C 2-naphtamides derivatives and therapeutic uses thereof |
| 05/11/2006 | WO2006049952A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/11/2006 | WO2006048389A1 Process for the synthesis of n-alkoxyamines |
| 05/11/2006 | US20060100460 Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds as VR1 receptor agonists |
| 05/11/2006 | US20060100438 Process of making fentanyl intermediates |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100245 Substituted biphenyl-4-carboxylic acid arylamide analogues |
| 05/11/2006 | US20060100243 Methylphenidate analogs and methods of use thereof |
| 05/11/2006 | US20060100242 4-(2-Phenylsulfanyl-phenyl)-piperidine derivates as serotonin reuptake inhibitors |
| 05/11/2006 | US20060100241 Method for enhancing mutant protein activity |
| 05/11/2006 | US20060100207 Dihydropyridinone derivatives |
| 05/11/2006 | US20060100196 Substituted amines for the treatment of alzheimer's disease |
| 05/11/2006 | US20060100106 Phenyl-substituted 2-enamino-ketonitriles |
| 05/11/2006 | CA2585645A1 Ceramides and apoptosis-signaling ligand |
| 05/10/2006 | EP1655303A2 Hydroxylamine esters as polimerization initiators |
| 05/10/2006 | EP1654260A2 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 05/10/2006 | EP1654230A1 Preparation of intermediates for acetyl cholinesterase inhibitors |
| 05/10/2006 | EP1654229A1 Piperidine derivatives as ccr5 receptor modulators |
| 05/10/2006 | EP1654224A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 05/10/2006 | EP1654216A1 Process for the hydrogenation of aromatic compounds |
| 05/10/2006 | EP1653945A2 Glycosidase inhibitors and methods of synthesizing same |
| 05/10/2006 | EP1358179B1 Synthesis method and intermediates of pyridin-2-yl-methylamine |
| 05/10/2006 | EP1282630B1 Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters |
| 05/10/2006 | EP1219605B1 Urea compounds, process for producing the same and use thereof |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771245A Novel crystals of fluorobenzamide derivative |
| 05/10/2006 | CN1771228A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof. |
| 05/10/2006 | CN1768745A Agents for improving excretory potency of urinary bladder |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255383C Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators |
| 05/10/2006 | CN1255382C Modulators of dopamine neurotransmission |
| 05/10/2006 | CN1255364C Method for reducing N oxo-compound |
| 05/09/2006 | US7041852 Perfluoroalkylanilines |
| 05/09/2006 | US7041830 oximation of isobutyl-(2-piperidinophenyl)-ketone with hydroxyl amine hydrochloride in an alcohol; reduction of oxime; solvent extraction, washing with brine, and evaporation; intermediate for the hypoglycemic agent, repaglinide; lower reaction temperatures; industrial scale synthesis |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041681 Nitrogen heterocyclic compounds, e.g., 3-(2-oxo-2-phenyl-ethylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester; treating pain and gastrointestinal disorders. |
| 05/09/2006 | US7041679 Crystallization, filtration; neurokinins receptor antagonist |
| 05/09/2006 | US7041678 Alkaloid that inhibits biosynthesis of mycotoxins and method for screening for mycotoxin inhibitors |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/04/2006 | WO2006046830A1 Preparing method for amorphous lercanidipine |
| 05/04/2006 | WO2006046131A1 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | WO2006045512A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 05/04/2006 | WO2006032994A3 Muscarinic receptor antagonists |
| 05/04/2006 | WO2006012227A3 Amido compounds and their use as pharmaceuticals |
| 05/04/2006 | US20060094880 Producing such as 1-{2-[2-(3,4-dimethoxy-phenyl)-ethoxy]-cyclohexyl}-pyrrolidin-3-ol; antiarrhythmia agents |
| 05/04/2006 | US20060094877 Process for preparation of benzylpiperidine compounds |
| 05/04/2006 | US20060094759 1-methyl-3-ethoxymethyl-4-(3,4-dichlorophenyl)-piperidine; nervous system disorders |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060094701 Respiratory system disorders; antiinflamamtory agents; side effect reduction; administering terbutaline |
| 05/04/2006 | US20060094671 With (-)-2'-deoxy-3'-thiocytidine-5'-triphosphate; immunomodulators; nucleosides |
| 05/04/2006 | CA2624934A1 Preparing method for amorphous lercanidipine |
| 05/04/2006 | CA2585014A1 Methylphenidate analogs and methods of use thereof |
| 05/04/2006 | CA2584547A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 05/03/2006 | EP1651643A2 Bicyclic compounds and compositions as pdf inhibitors |
| 05/03/2006 | EP1651603A1 Method for purification of amlodipine free base |
| 05/03/2006 | EP1651597A2 N-sulphonylated amino acid derivatives, method for the production and use thereof |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1651220A1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 05/03/2006 | EP1651219A2 Aripiprazole and haloperidol pamoate salts |
| 05/03/2006 | EP1562902B1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/03/2006 | EP1499590B1 Piperidine derivatives as potassium channel blockers |
| 05/03/2006 | EP1368006B1 Novel modified released formulation |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1133489B9 Isonipecotamides for the treatment of integrin-mediated disorders |
| 05/03/2006 | CN1768037A Chemical compounds. |
| 05/03/2006 | CN1767829A 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors. |
| 05/03/2006 | CN1765891A Novel aryloxy-alkyl-dialkylamines compound |
| 05/03/2006 | CN1765890A Modulators of dopamine neurotransmission |
| 05/03/2006 | CN1254467C Method for preparing 4-methylamino-4-phenylpiperidine |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7037942 Amide compounds for the potentiation of cholinergic activity |
| 05/02/2006 | US7037930 3-arylphenyl sulfide derivative and insecticide and miticide |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 04/27/2006 | WO2006044645A2 Sulfamoyl benzamides and methods of their use |
| 04/27/2006 | WO2006044230A1 Water soluble prodrugs of cox-2 inhibitors |